These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 34439875)
21. Evaluation of the Antifungal and Wound-Healing Properties of a Novel Peptide-Based Bioadhesive Hydrogel Formulation. Sultan AS; Vila T; Hefni E; Karlsson AJ; Jabra-Rizk MA Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332066 [TBL] [Abstract][Full Text] [Related]
22. The Interactions between the Antimicrobial Peptide P-113 and Living Cheng KT; Wu CL; Yip BS; Chih YH; Peng KL; Hsu SY; Yu HY; Cheng JW Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290246 [TBL] [Abstract][Full Text] [Related]
23. Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses. Pathirana RU; Friedman J; Norris HL; Salvatori O; McCall AD; Kay J; Edgerton M Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158282 [No Abstract] [Full Text] [Related]
24. How does it kill?: understanding the candidacidal mechanism of salivary histatin 5. Puri S; Edgerton M Eukaryot Cell; 2014 Aug; 13(8):958-64. PubMed ID: 24951439 [TBL] [Abstract][Full Text] [Related]
25. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL mBio; 2017 Dec; 8(6):. PubMed ID: 29208749 [No Abstract] [Full Text] [Related]
26. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation. Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913 [TBL] [Abstract][Full Text] [Related]
27. Loss of Upc2p-Inducible Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE mBio; 2018 May; 9(3):. PubMed ID: 29789366 [TBL] [Abstract][Full Text] [Related]
28. Histatin 5 inhibits adhesion of C. albicans to Reconstructed Human Oral Epithelium. Moffa EB; Mussi MC; Xiao Y; Garrido SS; Machado MA; Giampaolo ET; Siqueira WL Front Microbiol; 2015; 6():885. PubMed ID: 26379655 [TBL] [Abstract][Full Text] [Related]
29. Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype. Fitzgerald-Hughes DH; Coleman DC; O'Connell BC Antimicrob Agents Chemother; 2007 Aug; 51(8):2793-800. PubMed ID: 17485506 [TBL] [Abstract][Full Text] [Related]
30. Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis. Kong EF; Tsui C; Boyce H; Ibrahim A; Hoag SW; Karlsson AJ; Meiller TF; Jabra-Rizk MA Antimicrob Agents Chemother; 2016 Feb; 60(2):881-9. PubMed ID: 26596951 [TBL] [Abstract][Full Text] [Related]
31. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. O'Connell BC; Xu T; Walsh TJ; Sein T; Mastrangeli A; Crystal RG; Oppenheim FG; Baum BJ Hum Gene Ther; 1996 Dec; 7(18):2255-61. PubMed ID: 8953316 [TBL] [Abstract][Full Text] [Related]
35. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans. Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725 [TBL] [Abstract][Full Text] [Related]
36. Internalisation and degradation of histatin 5 by Candida albicans. Ruissen AL; Groenink J; Krijtenberg P; Walgreen-Weterings E; van 't Hof W; Veerman EC; Nieuw Amerongen AV Biol Chem; 2003 Jan; 384(1):183-90. PubMed ID: 12674513 [TBL] [Abstract][Full Text] [Related]